Keyphrases
Blood Loss
11%
Body Mass Index
11%
C-reactive Protein to Albumin Ratio
100%
Carbohydrate Antigen 19-9 (CA19-9)
11%
Carcinoembryonic Antigen
22%
Curative Intent
22%
Curative Surgery
100%
Disease-free Survival
22%
Early Recurrence
22%
Gastric Cancer
100%
Hazard Ratio
44%
Multivariate Analysis
22%
N Stage
11%
Overall Survival
22%
Pathological T Stage
11%
Poor Prognosis
22%
Recurrence Hazard
11%
Recurrence Prognosis
11%
Surgical Site Infection
33%
T Stage
11%
Timing of Surgery
22%
TNM Classification
11%
Treatment Burden
100%
Tumor Size
11%
Medicine and Dentistry
Body Mass Index
11%
C Reactive Protein
100%
CA19-9
11%
Cancer Staging
22%
Carcinoembryonic Antigen
22%
Disease Free Survival
22%
Hazard Ratio
44%
Multivariate Analysis
22%
Operative Blood Loss
11%
Overall Survival
22%
Recurrent Disease
22%
Stomach Cancer
100%
Surgical Infection
33%
Pharmacology, Toxicology and Pharmaceutical Science
C Reactive Protein
100%
Cancer Staging
22%
Carcinoembryonic Antigen
22%
Disease Free Survival
22%
Operative Blood Loss
11%
Overall Survival
22%
Recurrent Disease
22%
Stomach Cancer
100%
Surgical Infection
33%
Biochemistry, Genetics and Molecular Biology
Body Mass
11%
C-Reactive Protein
100%
CA19-9
11%
Cancer Staging
11%
Carcinoembryonic Antigen
22%
Disease Free Survival
22%
Multivariate Analysis
22%
Overall Survival
22%
Tumor Volume
11%
Immunology and Microbiology
Body Mass
11%
C-Reactive Protein
100%
Cancer Staging
11%
Carcinoembryonic Antigen
22%
Disease Free Survival
22%
Overall Survival
22%
Tumor Volume
11%